CG
Christopher Gagliardi
OtherActiveDirector of Investments at Sanofi Ventures
41
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Christopher Gagliardi.
Investment Thesis & Strategy
As Director of Investments at Sanofi Ventures, Christopher Gagliardi invests in various stages of biotech, consumer health, healthcare, health & hospital services, and health IT companies. He likely seeks companies that align with Sanofi's strategic interests and have the potential for significant impact in the healthcare industry.
Investment Activity
Deals per year over the last 1 years
1
2020Portfolio Companies
Selected investments from their portfolio of 41 companies
C
Curisium
Biotech · Seed, 0
I
Inozyme
Biotech · Series A, 0
i
i2o Therapeutics
Biotech · Seed, 0
D
DiCE Molecules
Biotech · Series A, 0
E
Escient Pharmaceuticals
Biotech · Series B, 0
E
Evidation Health
Healthcare · Series B, 0
C
Click Therapeutics
Healthcare · Series B, 0
L
Lava Therapeutics
Biotech · Series A, 0
L
Lumena Pharmaceuticals
Biotech · Series A, 0
V
Veralox Therapeutics
Biotech · Seed, 0
Q
Q32 Bio
Biotech · Series A, 0
I
ImmuneXcite
Biotech · Seed, 2020
Frequently Asked Questions
Christopher Gagliardi focuses on Series A stage investments.